Arbovirus Testing Market - By Test Type: ELISA, RT-PCR, Immunoassay, Others; By Virus Type: Dengue, Zika, Chikungunya, Yellow Fever, West Nile Virus, Others; By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Public Health Agencies; By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
1 | Market Overview
The global arbovirus testing market is rapidly expanding due to the increasing prevalence of arboviral infections such as dengue, Zika, chikungunya, West Nile virus, and yellow fever. These viruses, transmitted through arthropods like mosquitoes and ticks, pose serious public health threats, especially in tropical and subtropical regions. Arbovirus diagnostics are essential for surveillance, outbreak control, differential diagnosis, and monitoring of vaccine efficacy. Demand is driven by vector migration induced by global warming, urbanization, rising international travel, and recurrent outbreaks. Technologies in this market range from molecular (RT-PCR, LAMP) and serological (ELISA, immunofluorescence) tests to next-generation sequencing (NGS) and rapid point-of-care devices.
2 | Market Size and Forecast
|
Year |
Market Value (USD billion) |
Notes |
|
2019 |
1.06 |
Baseline value from regional outbreak response data |
|
2024 |
1.84 |
CAGR (2019–2024): 11.6% |
|
2031 |
4.67 |
CAGR (2024–2031): 14.2% |
The forecast reflects increasing integration of decentralized testing, expanded vector surveillance programs, and public health investment, particularly in Asia-Pacific and Latin America.
3 | Primary Market Drivers
4 | Market Challenges
5 | Competitive Landscape
|
Company |
Est. 2024 Share |
Strengths |
Recent Strategic Move |
|
|
Abbott Laboratories |
14% |
Point-of-care rapid tests, strong public-sector partnerships |
Deployed dual dengue-Zika rapid test across Southeast Asia |
|
|
Roche Diagnostics |
12% |
High-throughput RT-PCR, automation |
Added arbovirus panels to cobas® Liat system for outbreak response |
|
|
Thermo Fisher Scientific |
11% |
Reagents and molecular testing platforms |
Partnered with Caribbean labs to deploy mobile PCR stations |
|
|
Bio-Rad Laboratories |
9% |
Multiplex ELISA kits, vector surveillance tools |
Launched new IgM panel for flavivirus differentiation |
|
|
Qiagen |
8% |
RNA extraction and sample prep kits |
Introduced scalable vector monitoring workflow with qPCR integration |
|
6 | Detailed Market Segmentation
By Technology
By Virus Type
By End User
By Region
7 | Technology and Innovation
8 | Regulatory Environment
9 | Strategic Outlook
Need help?
Chat with our team in a minute.